Helium is one of the most overlooked, yet mission-critical, resources in healthcare supply chains. It supports core medical technologies, most notably MRI systems, and recent geopolitical disruptions have exposed just how fragile the global helium supply chain is.
Recent disruptions tied to the Iran conflict, particularly around Qatar—which produces roughly one-third of the world’s helium—have tightened supply and driven prices higher. Facility disruptions and shipping constraints have limited available volumes and left specialized helium containers stranded, according to The New York Times.
Key impacts include:
· Supplier rationing.
· Rising costs for hospitals and manufacturers.
· Increased risk of delays or limited access to imaging services.
· Longer lead times and prioritization of high-value uses over discretionary ones.
Most installed MRI systems still require large volumes of helium. If shortages persist, hospitals could face service disruptions, reduced imaging capacity, or higher operating costs. The impact may extend beyond imaging: helium shortages can also affect semiconductor manufacturing, with potential downstream effects on medical devices, AI technologies, and other digital health tools.
Healthcare leaders have flagged helium supply as a growing operational risk. At present, there is no scalable substitute for the large volumes of liquid helium needed to operate most MRI machines. While newer low-helium and helium-free MRI systems are emerging, they are not yet widely adopted. In periods of constrained supply, however, suppliers often prioritize medical imaging and critical manufacturing to preserve essential care capacity.
